| № | Name of the service | Unit | Price KZT |
| CLINICAL DIAGNOSTIC LABORATORY | |||
| ALLERGOLOGY | |||
| CDL - Allergens domestic/molecular (А) | |||
| 65 | CDL - Allergens domestic/molecular (А) | 1 test | 5 200 |
| 66 | CDL - Fungal allergens (D) | 1 test | 5 200 |
| 67 | CDL - Tree allergens (T) | 1 test | 5 200 |
| 68 | CDL - domestic dust allergens (H) | 1 test | 5 200 |
| 69 | CDL - Animal allergens(Е) | 1 test | 5 200 |
| 70 | CDL - airborne allergens (IР) | 1 test | 5 200 |
| 71 | CDL - medicinal allergens © | 1 test | 5 200 |
| 72 | CDL - insect allergens(I) | 1 test | 5 200 |
| 73 | CDL - Allergen parasite (P) | 1 test | 5 200 |
| 74 | CDL - Food allergens (F) | 1 test | 5 200 |
| 75 | CDL - Musty allergens (M) | 1 test | 5 200 |
| 76 | CDL - Occupational allergens (K) | 1 test | 5 200 |
| 77 | CDL - Other allergens (О) | 1 test | 5 200 |
| 78 | CDL - Weeds allergens (W) | 1 test | 5 200 |
| 79 | CDL - grass and herbs allergens (G) | 1 test | 5 200 |
| Biochemical study | |||
| Biochemical study. Protein exchange | |||
| 80 | Albumin | 1 test | 1 450 |
| 81 | Bence Jones protein test in urine | 1 test | 39 000 |
| 82 | Protein immunotyping ( M-gradient) | 1 test | 39 000 |
| 83 | Creatinine | 1 test | 1 170 |
| 84 | Uric acid | 1 test | 1 430 |
| 85 | Urea | 1 test | 1 360 |
| 86 | Total protein | 1 test | 1 300 |
| 87 | Blood protein electrophoresis ( protein fraction) | 1 test | 4 290 |
| Biochemical study. Iron exchange | |||
| 88 | Transferrin | 1 test | 3 250 |
| 89 | Ferritin | 1 test | 4 550 |
| Biochemical study. Lipoprotein exchange | |||
| 90 | Apolipoprotein A(Аро-А) | 1 test | 2 470 |
| 91 | Apolipoprotein B (Аро-В) | 1 test | 2 470 |
| 92 | Lipoprotein cholesterol high density (HDL) | 1 test | 2 600 |
| 93 | Lipoprotein cholesterol low density ( LDL) | 1 test | 2 340 |
| 94 | Triglyceride | 1 test | 1 300 |
| 95 | Cholesterol | 1 test | 1 620 |
| Biochemical study. Pigment exchange | |||
| 96 | Total bilirubin | 1 test | 1 390 |
| 97 | Conjugated bilirubin | 1 test | 1 430 |
| Biochemical study. Carbohydrate exchange | |||
| 98 | Glycated hemoglobin (hemoglobin А1с, HbA1c) | 1 test | 3 770 |
| 99 | Glucose | 1 test | 1 170 |
| 100 | Glucose on glucometer | 1 test | 520 |
| Biochemical study. Enzymes | |||
| 101 | ALAT | 1 test | 1 300 |
| 102 | α-amylase | 1 test | 2 470 |
| 103 | Pancreas α-amylase | 1 test | 4 290 |
| 104 | ASAT aspartate transaminase | 1 test | 2 340 |
| 105 | Gamma glutamine transferase (GGT) | 1 test | 3 120 |
| 106 | Creatine kinase-MB fraction | 1 test | 2 270 |
| 107 | Creatine phosphokinase | 1 test | 2 340 |
| 108 | Lactate dehydrogenase | 1 test | 2 600 |
| 109 | Acid phosphatase | 1 test | 1 750 |
| Biochemical study of urine | |||
| 110 | Glucose in one-time portion | 1 test | 1 750 |
| 111 | Glucose in daily portion | 1 test | 1 880 |
| 112 | Urine Ca++ | 1 test | 1 820 |
| 113 | Urine creatinine | 1 test | 1 560 |
| 114 | Urine Mg++ | 1 test | 1 560 |
| 115 | Urine uric acid | 1 test | 1 560 |
| 116 | Urine urea | 1 test | 1 690 |
| 117 | Microalbuminous complex (ratio creatinine/albumin) | 1 test | 10 790 |
| 118 | Relative index metabolic disorders (ratio calcium/creatinine, magnesium/creatinine, inorganic phosphorus/creatinine, uric acid/creatinine | 1 test | 5 330 |
| 119 | Relative index metabolic disorders (ratio calcium/creatinine) | 1 test | 3 770 |
| 120 | Relative index metabolic disorders (ratio magnesium/creatinine) | 1 test | 4 030 |
| 121 | Relative index metabolic disorders (ratio inorganic uric acid/creatinine) | 1 test | 3 510 |
| 122 | Relative index metabolic disorders (ratio inorganic phosphorus/creatinine) | 1 test | 3 380 |
| 123 | Rehberg Test | 1 test | 3 900 |
| 124 | Speed in glomerular filtration | 1 test | 3 120 |
| 125 | Urine osmolarity | 1 test | 780 |
| 126 | Urine phosphorus | 1 test | 1 300 |
| 127 | Urine potassium | 1 test | 1 300 |
| 128 | Sodium urine | 1 test | 1 300 |
| 129 | Chloride urine | 1 test | 1 300 |
| Biochemistry | |||
| 130 | Blood osmolarity | 1 test | 1 950 |
| Immune status | |||
| 131 | Immunoglobulin A | 1 test | 3 120 |
| 132 | Immunoglobulin G | 1 test | 3 120 |
| 133 | Immunoglobulin M | 1 test | 3 120 |
| 134 | Complement C3 | 1 test | 5 200 |
| 135 | Complement C4 | 1 test | 3 770 |
| Hemostasis testing | |||
| 136 | Thrombocyte aggregation with P2Y ( PFA 200 analyzer) | 1 test | 30 290 |
| 137 | Thrombocyte aggregation with ADP (PFA 200) | 1 test | 30 290 |
| 138 | Thrombocyte aggregation with epinephrin (PFA 200) | 1 test | 28 600 |
| 139 | Activated partial/batch thromboplastin time (APTT/PTT) | 1 test | 1 950 |
| 140 | Antithrombin III (АТ-3) | 1 test | 4 030 |
| 141 | lupus anti-coagulant (Lupus-test) | 1 test | 5 850 |
| 142 | Bleeding time | 1 test | 1 300 |
| 143 | Blood clotting time | 1 test | 1 300 |
| 144 | D-Dimer Exclusion | 1 test | 10 660 |
| 145 | D-Dimer Exclusion quantitative test | 1 test | 13 000 |
| 146 | Coagulogram (APTT, INR, HQ, fibrinogen, thrombine,…) | 1 test | 5 200 |
| 147 | Coagulogram+SFC (APTT, INR, PT, PTI, fibrinogen, thrombine) | 1 test | 7 150 |
| 148 | International normalized ratio | 1 test | 1 430 |
| 149 | Protein C | 1 test | 4 160 |
| 150 | Prothrombin time | 1 test | 1 300 |
| 151 | Prothrombin index HQ | 1 test | 1 300 |
| 152 | SFC (Soluble fibrin complex) | 1 test | 1 950 |
| 153 | С1-inhibitir | 1 test | 15 600 |
| 154 | Thrombine time | 1 test | 1 430 |
| 155 | Thromboelastogram with heparinase | 1 test | 15 210 |
| 156 | Thromboelastogram with caoline | 1 test | 11 700 |
| 157 | Fibrinogen | 1 test | 1 950 |
| Specific proteins | |||
| 158 | Antitripsin α-1 | 1 test | 6 240 |
| 159 | Antistreptolozin O (quantitative) | 1 test | 3 640 |
| 160 | Gaptoglobulin | 1 test | 2 080 |
| 161 | Myoglobin quantitative | 1 test | 2 820 |
| 162 | Rheumatoid factor (quantitative) | 1 test | 2 990 |
| 163 | C-reactive protein (quantitative) | 1 test | 3 120 |
| 164 | Ceruloplasmin | 1 test | 5 300 |
| Electrolytes, mineral exchange | |||
| 165 | TSH receptor antibodies (anti-рTSH, TSH receptor antibodies, a-rTSH) | 1 test | 11 180 |
| 166 | Ionized calcium | 1 test | 4 290 |
| 167 | Serum iron (Fe) | 1 test | 2 340 |
| 168 | K | 1 test | 1 300 |
| 169 | Ca | 1 test | 1 560 |
| 170 | Acid-base balance ( blood gas) | 1 test | 7 020 |
| 171 | Mg | 1 test | 2 080 |
| 172 | Cu | 1 test | 1 620 |
| 173 | NA | 1 test | 1 300 |
| 174 | P | 1 test | 2 210 |
| 175 | Cl | 1 test | 1 300 |
| 176 | Electrolytes (К,NA, ionized calcium, CI) in blood serum | 1 test | 5 850 |
| Hematologic tests | |||
| 177 | LE cells, lupous | 1 test | 3 900 |
| 178 | Malaria test | 1 test | 1 620 |
| 179 | Blood test (with WCC) | 1 test | 2 860 |
| 180 | Blood test (without WCC) | 1 test | 1 560 |
| 181 | Reticulocyte calculation | 1 test | 1 560 |
| 182 | Platelets according to Phonio | 1 test | 1 560 |
| Immune status | |||
| 183 | Cell immunity | 1 test | 24 700 |
| 184 | Phagocytosis (with oxygen) | 1 test | 13 650 |
| IMMUNOLOGY | |||
| Vitamins | |||
| 185 | Vitamin D total, 25-OH-VitD | 1 test | 7 150 |
| 186 | Vitamin D3, 25-OH-VitD3 | 1 test | 8 840 |
| 187 | Vitamin B12, Cyanocobalamin | 1 test | 3 900 |
| 188 | active Vitamin B12, Holotranscobalamin | 1 test | 8 320 |
| 189 | Folate | 1 test | 4 030 |
| Gastropanel BIOHIT | |||
| 190 | Gastric mucosa ( pepsinogen I , II; gastrin -17B, -17S; а-Helicobacter pylori IgG) | 1 test | 29 900 |
| Hypophysial-adrenic system hormones | |||
| 191 | Adrenocorticotropic hormone, ACTH | 1 test | 5 460 |
| 192 | Aldosterone | 1 test | 5 460 |
| 193 | Growth hormone (hGH) | 1 test | 6 500 |
| 194 | Dehydroepiandrosterone sulfate (DHEA-s) | 1 test | 6 500 |
| 195 | Cortisol | 1 test | 5 200 |
| 196 | Catecholamine level detection (adrenalin, noradrenaline, dopamine) in a blood plasma | 1 test | 29 900 |
| 197 | Melatonin in blood serum, quantity | 1 test | 18 850 |
| Hypophysial-adrenic system hormones in urine | |||
| 198 | Adrenalin (epinephrin) in a blood serum, quantity | 1 test | 18 850 |
| 199 | Dopamine in a blood serum, quantity | 1 test | 18 850 |
| 200 | Noradrenaline (norepinephrine ) in a blood serum, quantity | 1 test | 18 850 |
| 201 | VMA, 24h urine | 1 test | 7 150 |
| 202 | HVA, 24h urine | 1 test | 7 150 |
| 203 | Cortisol, 24h urine | 1 test | 6 370 |
| Pancreas hormones | |||
| 204 | Insulin | 1 test | 4 030 |
| 205 | C-Peptide | 1 test | 4 550 |
| Reproductive system hormones | |||
| 206 | Anti-Mullerian Hormone АМН, MIS | 1 test | 9 750 |
| 207 | Globulin, which connects reproductive hormones, SHBG | 1 test | 6 240 |
| 208 | Luteinizing hormone LH | 1 test | 2 860 |
| 209 | Progesterone | 1 test | 3 250 |
| 210 | Prolactin | 1 test | 2 990 |
| 211 | Testosterone | 1 test | 4 160 |
| 212 | Follicle-stimulating hormone, FSH | 1 test | 2 860 |
| 213 | Estradiol | 1 test | 3 510 |
| Hormone tests. Thyroid | |||
| 214 | Anti-Tg | 1 test | 4 550 |
| 215 | Anti-TPO | 1 test | 3 770 |
| 216 | Tg | 1 test | 4 550 |
| 217 | TSH | 1 test | 3 250 |
| 218 | total Т4 | 1 test | 3 900 |
| 219 | FT4 | 1 test | 3 380 |
| 220 | total Т3 | 1 test | 3 510 |
| 221 | FТ3 | 1 test | 3 510 |
| EIA, ECLIA | |||
| 222 | Antimitochondrial antibody subtype М2 (АМА-М2) | 1 test | 8 840 |
| 223 | ANCA-screen | 1 test | 17 550 |
| 224 | ANA screen | 1 test | 8 840 |
| 225 | ANA-Detect | 1 test | 8 840 |
| 226 | Antibody GBM in a blood serum | 1 test | 10 790 |
| 227 | Anti-ß-2 Glycoprotein I | 1 test | 8 710 |
| 228 | a-dsDNA | 1 test | 8 840 |
| 229 | а-ssDNA | 1 test | 8 840 |
| 230 | a-Parietal cell IgG | 1 test | 8 840 |
| 231 | а-tTG IgA,G | 1 test | 8 840 |
| 232 | Anti-Elastase | 1 test | 8 840 |
| 233 | ASCA IgA to Saccharomyces cerevisiae | 1 test | 8 840 |
| 234 | ASCA IgG to Saccharomyces cerevisiae | 1 test | 8 840 |
| 235 | a-Histone IgG | 1 test | 9 750 |
| 236 | A-Cardiolipin IgG | 1 test | 9 750 |
| 237 | A-MCV IgG | 1 test | 10 660 |
| 238 | AFL IgG | 1 test | 9 620 |
| 239 | A-Cardiolipin IgM | 1 test | 9 620 |
| 240 | AFL IgM | 1 test | 8 840 |
| 241 | Anti-Protrombin) | 1 test | 8 840 |
| 242 | A-insulin | 1 test | 9 750 |
| 243 | A-Cardiolipin total | 1 test | 8 840 |
| 244 | ENA screen | 1 test | 28 340 |
| 245 | ANCA-combi | 1 test | 43 940 |
| 246 | ANA combi | 1 test | 31 850 |
| 247 | АSА | 1 test | 14 300 |
| 248 | а-ССР | 1 test | 19 760 |
| 249 | Insulin antibody in a blood serum | 1 test | 6 500 |
| 250 | ENA screen | 1 test | 8 450 |
| 251 | "ANA pro" antibody IgG | 1 test | 26 000 |
| Autoimmune pathology (LIA-tests) | |||
| 252 | Antibodies of autoimmune vasculitis IMTEC-Vasculitis-LIA (IgG to PR3, MPO and GBM) | 1 test | 34 060 |
| 253 | Antibodies of liver autoimmune diseases IMTEC- Liver-LIA S (IgG to AMA M2, Sp100, LKM1, gp210, LC1 and SLA) | 1 test | 17 550 |
| 254 | ANA-LIA (IgG to nucleosome, DNA, histone, SmD1, U1-snRNP, SS-A/Ro60kD, SS- A/Ro52kD, SS-B/La, Scl70, CENP-B, Jo1, P0) | 1 test | 8 060 |
| 255 | Antinuclear antibody ANA-LIA MAXX: IgG к nucleosome ,DNA,histone,SmD1, PCNA,P0,SS-A/Ro60и52kD,SS–B/La,CENP-B,Scl-70,U1-snRNP,AMA M2,Jo-1,PM-Scl,Mi-2 (β),Ku | 1 test | 35 880 |
| 256 | Autoimmune myositis antibody detection IMTEC-Myositis-LIA (IgG to Jo1, Mi2, PM-Scl, U1-snRNP and Ku) | 1 test | 18 330 |
| 257 | IMTEC-Celiac Disease-LIA S (IgA и IgG to gliadine, tissue) | 1 test | 7 800 |
| 258 | Gastro-LIA (IgA и IgG to gladine, tTG, mannanu, РСА) | 1 test | 24 440 |
| Diagnostic of autoimmune pathology by indirect immunofluorescence method (IFA) | |||
| 259 | Anti-keratic antibodies (AKA) by indirect immunofluorescence method (IFA) | 1 test | 7 540 |
| 260 | ANCA by indirect immunofluorescence method (IFA) | 1 test | 7 150 |
| 261 | Antinuclear factor on cell line HEp-2 by indirect immunofluorescence method (IFA) | 1 test | 6 370 |
| 262 | а-nDNA by indirect immunofluorescence method (IFA) | 1 test | 7 150 |
| 263 | Autoantibody (IFA) on triple substrate (LKM-1, antibodies to parietal cell, to smooth muscle(F-actine), ANA on cell line HЕp-2, АМА-М1,9) | 1 test | 7 410 |
| Immune status | |||
| 264 | Alpha interferon | 1 test | 10 400 |
| 265 | Gamma interferon | 1 test | 10 400 |
| 266 | Immunoglobulin А secretory in a blood serum (sIgA ) | 1 test | 6 240 |
| 267 | Immunoglobulin Е total (total IgE) | 1 test | 6 890 |
| 268 | Immunophenotyping HLA B27 in a blood with ductal cytofluorometry | 1 test | 26 000 |
| 269 | Interleukin-10 | 1 test | 8 450 |
| 270 | Interleukin-2 | 1 test | 10 400 |
| 271 | Interleukin-6 | 1 test | 10 400 |
| 272 | Interleukin-8 | 1 test | 8 450 |
| 273 | Interleukin level - 13 in a blood serum and plasma | 1 test | 22 750 |
| 274 | Interleukin level - 3 in a blood serum and plasma | 1 test | 40 300 |
| 275 | Interleukin level - 5 in a blood serum and plasma | 1 test | 22 750 |
| 276 | Interleukin - 1β (IL-1-β) in biological fluid of human and cultural envirenment, quantity | 1 test | 11 440 |
| 277 | Interleukin - 13 (IL-13) in a blood serum, quantity | 1 test | 12 350 |
| 278 | Interleukin - 18 (IL-18) in a blood serum, quantity | 1 test | 9 880 |
| 279 | Interleukin - 3 (IL-3) in a blood serum, quantity | 1 test | 12 350 |
| 280 | Interleukin - 4 (IL-4) in a blood serum, quantity | 1 test | 10 140 |
| 281 | Interleukin - 5 (IL-5) in a blood serum, quantity | 1 test | 12 350 |
| 282 | ECP | 1 test | 7 930 |
| 283 | Tryptase | 1 test | 10 140 |
| Serological markers of SARS-CoV-2 (COVID-19, 2019-nCoV) | |||
| 284 | IgМ к SARS-CoV-2 (quality) | 1 test | 5 590 |
| 285 | IgG к SARS-CoV-2 (quality) | 1 test | 5 650 |
| 286 | nCoV - Nab (postvaccinal, quantity) | 1 test | 6 500 |
| 287 | Immunoglobulin G to SARS- CoV-2 quantity | 1 test | 6 500 |
| 288 | Immunoglobulin M to SARS- CoV-2 quantity | 1 test | 7 800 |
| 289 | IgG/IgM antibody to SARS-CoV-2 (rapid test) quality | 1 test | 8 450 |
| 290 | Specific antigen Sars-CoV-2 (rapid test) quality | 1 test | 7 020 |
| Drug monitoring | |||
| 291 | Tacrolimus in a blood serum by immunochemiluminescence method | 1 test | 12 480 |
| Sepsis markers | |||
| 292 | Procalcitonin, РСТ (quantitation by immunoenzyme method) | 1 test | 11 440 |
| 293 | Procalcitonin, РСТ ( quantitation by immunofluorescence method) | 1 test | 11 310 |
| Osteal metabolism | |||
| 294 | N-MID Osteocalcin | 1 test | 5 200 |
| 295 | Parathyroid hormone PTH | 1 test | 5 200 |
| 296 | Pyrilinks-D, DPD | 1 test | 4 680 |
| Tumor marker | |||
| 297 | AFP | 1 test | 4 680 |
| 298 | SCC-Ag | 1 test | 5 070 |
| 299 | Calcitonin | 1 test | 6 500 |
| 300 | Neuron-specific enolase (НСЕ, NSE) in a blood serum with immunochemiluminescence | 1 test | 6 890 |
| 301 | РroGRP | 1 test | 6 890 |
| 302 | PSA total | 1 test | 3 770 |
| 303 | PSA free | 1 test | 3 510 |
| 304 | СЕА | 1 test | 4 420 |
| 305 | СА 72-4 | 1 test | 8 450 |
| 306 | СА 125 | 1 test | 5 460 |
| 307 | СА 15-3 | 1 test | 5 070 |
| 308 | СА 19-9 | 1 test | 5 330 |
| 309 | СА 242 | 1 test | 10 660 |
| 310 | TNF-α | 1 test | 7 150 |
| 311 | Cyfra21-1 | 1 test | 7 150 |
| 312 | HCG+beta | 1 test | 7 150 |
| 313 | HCG urine | 1 test | 5 850 |
| 314 | HCG | 1 test | 3 050 |
| 315 | НЕ4 | 1 test | 8 450 |
| Other investigations | |||
| 316 | Нсу-SН | 1 test | 8 450 |
| 317 | ЕРО | 1 test | 5 590 |
| 318 | Determination of pancreatic elastase in a stool | 1 test | 19 500 |
| Brucellosis diagnostics | |||
| 319 | A antibodies to brucellosis | 1 test | 5 200 |
| 320 | G antibodies to brucellosis | 1 test | 5 200 |
| 321 | M antibodies to brucellosis | 1 test | 5 200 |
| Serology. Hepatitis D | |||
| 322 | Hepatitis D antibodies (A-HDV total) | 1 test | 3 900 |
| Serology. Hepatitis A | |||
| 323 | а-HAV IgM | 1 test | 3 120 |
| Serology. Hepatitis B | |||
| 324 | HBeAg | 1 test | 3 310 |
| 325 | а-HBeAg IgG | 1 test | 2 990 |
| 326 | а-HBcAg IgG | 1 test | 3 510 |
| 327 | а-HBcAg IgМ | 1 test | 3 380 |
| 328 | НBsAg | 1 test | 3 120 |
| 329 | а-HBeAg total | 1 test | 3 380 |
| 330 | а-HBsAg total | 1 test | 3 770 |
| 331 | а-HBcAg total | 1 test | 4 160 |
| 332 | НBsAg, rapid-test | 1 test | 2 340 |
| Serology. Hepatitis C | |||
| 333 | Ag HCV | 1 test | 11 050 |
| 334 | HCV IgM | 1 test | 4 550 |
| 335 | а-HCV total | 1 test | 3 740 |
| 336 | a-HCV, rapid-test | 1 test | 2 470 |
| Serology. HIV infection | |||
| 337 | Ag HIV p24 and Ab to HIV in 1, 2 types (HIV-1 and HIV-2) | 1 test | 3 900 |
| 338 | Lateral flow assay of III generation for Ab to HIV-1/2 types (a-HIV-1/2) cito | 1 test | 2 600 |
| 339 | Free Ag HIV-1 p24 ab and Ab to HIV-1/2 types (a-HIV-1/2) cito | 1 test | 4 160 |
| 340 | EIA HIV antibody (HIV center) | 1 test | 3 250 |
| Serology. Herpes infection | |||
| 341 | HSV-8-IgG | 1 test | 3 510 |
| 342 | HSV-1,2-IgG | 1 test | 3 900 |
| 343 | HSV-1-IgG | 1 test | 2 790 |
| 344 | HSV-2-IgG | 1 test | 3 640 |
| 345 | HHV-6-IgG | 1 test | 3 900 |
| 346 | HSV-1,2-IgM | 1 test | 3 640 |
| 347 | HSV-2-IgM | 1 test | 4 290 |
| 348 | HSV-1-IgM | 1 test | 3 250 |
| 349 | HSV–1,2-IgG–Avidity | 1 test | 4 030 |
| 350 | HSV–2-IgG–Avidity | 1 test | 4 030 |
| Serology. infectious mononucleosis | |||
| 351 | EBV-EA IgG | 1 test | 4 160 |
| 352 | EBV-NA IgG | 1 test | 4 160 |
| 353 | EBV-VCA IgG | 1 test | 4 160 |
| 354 | EBV-VCA IgM | 1 test | 4 160 |
| 355 | EBV-VCA IgG-Avidity | 1 test | 4 550 |
| Serology. Rubella | |||
| 356 | Rubella IgG | 1 test | 3 380 |
| 357 | Rubella IgM | 1 test | 3 640 |
| 358 | Rubella IgG-Avidity | 1 test | 4 160 |
| Serology. Listeria markers | |||
| 359 | G to Listeria monocytogenes | 1 test | 2 860 |
| Cytomegalovirus infection | |||
| 360 | CMV–IЕА–IgG/М | 1 test | 4 680 |
| 361 | СMV IgG | 1 test | 4 810 |
| 362 | СMV IgM | 1 test | 4 680 |
| 363 | СMV-IgG-Avidity | 1 test | 4 550 |
| Serology. Antibodies to parasites and fungis | |||
| 364 | Candida albicans IgG | 1 test | 4 550 |
| 365 | Trichomonas vaginalis IgA | 1 test | 4 550 |
| 366 | Ascaris lumbricoides IgG | 1 test | 4 550 |
| 367 | Aspergillus IgG | 1 test | 4 550 |
| 368 | a-Opistоrhide IgG | 1 test | 4 550 |
| 369 | a-Toxocara IgG | 1 test | 4 550 |
| 370 | a-Trichinella IgG | 1 test | 4 550 |
| 371 | а-Echinococcus IgG | 1 test | 4 550 |
| 372 | Toxoplasma gondii IgG | 1 test | 4 550 |
| 373 | Trichomonas vaginalis IgG | 1 test | 4 550 |
| 374 | Toxoplasma gondii IgА | 1 test | 4 550 |
| 375 | Toxoplasma gondii IgМ | 1 test | 4 550 |
| 376 | Toxoplasma gondii IgG–Avidity | 1 test | 3 770 |
| 377 | Specific circulatory immunocomplex (SCI),containing opistarchosis | 1 test | 4 940 |
| 378 | а-Lamblia total | 1 test | 3 900 |
| Serology. Bacterial antibodies | |||
| 379 | Mycoplasma hominis IgA | 1 test | 3 900 |
| 380 | Ureaplasma urealyticum IgA | 1 test | 3 900 |
| 381 | Ureaplasma urealyticum IgG | 1 test | 3 900 |
| 382 | Ab G to Helycobacter pylori | 1 test | 3 900 |
| 383 | IgG Chlamydia trachomatis (HSP60), early diagnostic | 1 test | 2 860 |
| 384 | IgG to main protein of external membrane and plasmid protein pgp3 Chlamydia trachomatis | 1 test | 3 380 |
| 385 | Mycoplasma hominis IgG | 1 test | 3 900 |
| 386 | Chlamydia trachomatis IgG | 1 test | 3 900 |
| 387 | Chlamydia trachomatis IgM | 1 test | 3 900 |
| 388 | Chlamydia trachomatis IgA | 1 test | 3 900 |
| 389 | A, M, G к Cag Helycobacter pylori | 1 test | 3 900 |
| 390 | A, M, G а-Mycobacterium Tuberculosis | 1 test | 4 160 |
| 391 | Treponema pallidum total | 1 test | 4 160 |
| Specific proteins | |||
| 392 | NT-pro BNP | 1 test | 8 710 |
| 393 | TNI | 1 test | 9 620 |
| 394 | TNI high sensetivity, quantity | 1 test | 11 310 |
| 395 | TNI and myoglobine cito | 1 test | 3 050 |
| Urine specific proteins | |||
| 396 | Neutrophil gelatinase-associated lipocalin, NGAL | 1 test | 8 320 |
| MICROBIOLOGY | |||
| Bacteriological tests | |||
| 397 | Bacteriologic biomaterial research of autopsi material | 1 test | 8 450 |
| 398 | Bacteriologic biomaterial research of staphylococcus from nose | 1 test | 7 150 |
| 399 | Bacteriologic biomaterial research of anaerobic organism | 1 test | 7 410 |
| 400 | Bacteriologic biomaterial research of yersiniosis | 1 test | 7 150 |
| 401 | Bacteriologic biomaterial research of meningococcus | 1 test | 9 100 |
| 402 | Bacteriologic microflora research | 1 test | 11 700 |
| 403 | Bacteriologic biomaterial research of causative agent of diphteria | 1 test | 8 450 |
| 404 | Bacteriologic biomaterial research of phungi with type identification | 1 test | 8 190 |
| 406 | Bacterial blood test for Salmonella hemoccult on analyzer | 1 test | 10 920 |
| 407 | Bacterial test for streptococcus group B | 1 test | 18 850 |
| 408 | Biomaterial sampling for microbiological study | 1 test | 1 560 |
| 409 | Intestinal dismicrobism | 1 test | 18 200 |
| 410 | Bacteriological research of fecal on pathogenic and potentially pathogenic gut microflora with sensibilety detection | 1 test | 6 760 |
| 411 | Disinfectant efficiency determination | 1 test | 2 730 |
| 412 | PASTOREX Meningitis | 1 test | 28 600 |
| Sanitary-and-bacteriologic test | |||
| 413 | Air research | 1 test | 2 730 |
| 414 | Sterility test of liquid medical forms and materials (10 investigations) | 1 test | 4 290 |
| 415 | Bacteriology researches of environment on collon bacillus pathologic flora, stap. | 1 test | 1 950 |
| Sputum test | |||
| 416 | Sputum mycobacterium tuberculosis test (urine, sputum, cerebro spinial, pleural fluid, station etc.) | 1 test | 3 120 |
| Parasitologic stool investigation | |||
| 417 | Stool for eggs with concentrator | 1 test | 3 250 |
| 418 | Stool protozoa and eggs | 1 test | 2 080 |
| Serology. Syphilis | |||
| 419 | Microreaction | 1 test | 1 620 |
| 420 | RW | 1 test | 4 810 |
| 421 | Syphilis, express test (Treponema pallidum) | 1 test | 4 420 |
| Molecular-biological analysis (PCR) | |||
| PCR-bacterilogical infection diagnostic | |||
| 422 | DNA Brucella species | 1 test | 6 500 |
| 423 | Mycoplasma pneumoniae/Chlamydophila pneumoniae DNA | 1 test | 8 060 |
| 424 | DNA Мucobacterium tuberculosis | 1 test | 4 680 |
| 425 | DNA Toxoplasma gondii | 1 test | 4 550 |
| PCR-viral hepatitis diagnostic | |||
| 426 | Hepatitis С: 1a, 1b, 2, 3a, 3b HCV Genotyping/Subtyping) | 1 test | 16 380 |
| 427 | DNA hepatitis B, HBV DNA Qualitative | 1 test | 11 050 |
| 428 | DNA hepatitis B HBV DNA Quant. | 1 test | 15 340 |
| 429 | HDV RNA Qualitative | 1 test | 12 350 |
| 430 | RNA HCV Quant. | 1 test | 17 160 |
| 431 | HDV RNA Qualitative | 1 test | 12 090 |
| PCR-viral infections diagnostic | |||
| 432 | PCR-diagnostic COVID-19 | 1 test | 9 750 |
| 433 | DNA Cytomegalovirus quant. | 1 test | 13 000 |
| 434 | Quantity DNA Gardnerella vaginalis etc. (florecenos/ bacterial vaginosis) | 1 test | 6 110 |
| 435 | High-risk НРV DNA | 1 test | 13 650 |
| 436 | DNA Varicella-Zoster virus, DNA VZV | 1 test | 3 250 |
| 437 | DNA Rubella virus | 1 test | 3 380 |
| 438 | DNA НРV 16/18 | 1 test | 7 800 |
| 439 | DNA HSV 1, 2 | 1 test | 7 800 |
| 440 | DNA EBV Qualitative | 1 test | 3 900 |
| 441 | DNA EBV Quant | 1 test | 7 800 |
| 442 | DNA acute respiratory viral infection | 1 test | 8 450 |
| 443 | DNA Cytomegalovirus | 1 test | 9 750 |
| PCR-urogenital diagnostic | |||
| 444 | Quantity DNA ureaplasma, mycoplasma (florecenos/ureaplasma, mycoplasma) | 1 test | 5 980 |
| 445 | Quantity DNA candida (florecenos/candida) | 1 test | 5 850 |
| 446 | Candida albicans | 1 test | 4 810 |
| 447 | Chlamydia trachomatis | 1 test | 4 810 |
| 448 | Gardnerella vaginalis | 1 test | 4 810 |
| 449 | Mycoplasma genitalum | 1 test | 4 810 |
| 450 | Mycoplasma hominis | 1 test | 4 810 |
| 451 | Neisseria gonorrhoeae | 1 test | 4 810 |
| 452 | Trichomonas vaginalis | 1 test | 4 810 |
| 453 | Ureaplasma species | 1 test | 4 810 |
| PCR-other infections | |||
| 454 | Ascaris lumbricoides, Enterobius vermicularis, Opisthorchis felineus, Taenia solium, Diphyllobothrium latum | 1 test | 9 810 |
| 455 | Lamblia Intestinalis Giardia, Blastocystis hominis, Dientamoeba fragilis, Isospora belli, Cryptosporidium parvum, Entamoeba histolytica | 1 test | 9 810 |
| General clinic | |||
| General clinic stool test | |||
| 456 | Stool occult blood | 1 test | 2 860 |
| 457 | Helicobacter pylori (quantity, express test) | 1 test | 5 460 |
| 458 | Calprotectin (quality, express test) | 1 test | 8 450 |
| 459 | Calprotectin (quantity, immunoferment method) | 1 test | 13 000 |
| 460 | Coprogram | 1 test | 3 900 |
| Urine examination | |||
| 461 | Protein in 24h urine | 1 test | 2 210 |
| 462 | Urine examination | 1 test | 2 600 |
| 463 | 24h urine examination | 1 test | 2 600 |
| 464 | Microalbumin in one time portion of urine (partiallyquantitative) | 1 test | 1 300 |
| 465 | General sputum | 1 test | 2 600 |
| 466 | General urine | 1 test | 1 820 |
| 467 | Rhinocytogram (cell) | 1 test | 2 860 |
| 468 | Three-glass test | 1 test | 1 690 |
| General clinic examinations of urethral and vaginal discharge | |||
| 469 | Microscopic study of urethra discharge ( urethra smear) | 1 test | 2 990 |
| 470 | Microscopic study of prostatic fluid (prostata gland) | 1 test | 2 990 |
| 471 | Purity test of gynecological smear | 1 test | 3 900 |
| 472 | Spermogram with detection of sperm morphology | 1 test | 11 050 |
| 473 | MAR-test | 1 test | 9 750 |
| General clinic examination of other biomaterial | |||
| 474 | Demodex | 1 test | 2 600 |
| 475 | Pathogenic fungi | 1 test | 2 210 |
| 476 | Cerebrospinal fluid (CSF) | 1 test | 1 560 |
| 477 | Duodenal content (bile) | 1 test | 3 640 |
| 478 | Serous cavity fluids and cyst (exudate, transudate) | 1 test | 1 690 |
| 479 | Microscopic smear colored by Romanovsky | 1 test | 2 470 |
| 480 | Microscopic smear of a skin scrape for scabies mites. | 1 test | 2 600 |
| Genomic laborotory | |||
| 481 | Molecular genetic mutation analysis, chimerical transcripts and copy number in 52 key gens connected with canceration | 1 test | 585 000 |
| 482 | Molecular genetic mutation analysis, chimerical transcripts and copy number in 69 key gens connected with development of myeloic disorder | 1 test | 624 000 |
| 483 | Molecular genetic diagnostic of mutation V600Е in gen BRAF from tumor cells, enclosed in paraffin section | 1 test | 37 700 |
| 484 | Molecular genetic diagnostic of mutation in ALK gen from tumor cells, enclosed in paraffin section | 1 test | 58 500 |
| 485 | Full-exome sequencing of human DNA to search suspicious genetic condition with result interpretation | 1 test | 1 430 000 |
| 486 | Gen mutation HLA class II - DQ2, DQ8, DQA1*05 with Gee's disease PCR in real time | 1 test | 117 000 |
| 487 | FISH diagnostic of bone marrow cells for detection chimeric gene BCR/ABL t(9;22), CML and ALLрh+ | 1 test | 65 060 |
| 488 | FISH diagnostic of carcinoma of bladder for detection aneuploidy 3, 7, 17 chromosomes and deletion 9р21 gene locus | 1 test | 96 200 |
| 489 | FISH diagnostic of numeral chromosomal pathologies 13, 18, 21, X and Y in amniotic fluid | 1 test | 76 700 |
| 490 | Chimeric gene qualitative BCR/ABL-t(9;22), PCR in real time | 1 test | 20 800 |
| 491 | Chimeric gene quantitative BCR/ABL-t(9;22), PCR in real time | 1 test | 35 100 |
| 492 | Molecular genetic diagnostic with MLPA large deletion/duplication in gens SMN1 and SMN2, associated with spinal muscular atrophy | 1 test | 91 650 |
| 493 | Minimal residual disease | 1 test | 35 100 |
| 494 | Mutation DMD gene during Duchenne muscular dystrophy MLPA | 1 test | 91 650 |
| 495 | Standard cytogenetic test (karyotyping) peripheral blood cells | 1 test | 39 000 |
| 496 | Quantative and qualitative molecular genetic diagnostic of chimeric gene BCR/ABL-t(9;22), transcript typing BCR/ABL gene duting gemo | 1 test | 55 900 |
| 497 | Molecular genetic analysis (genotyping) in gene mutation, associated with arterial hypertension development risk and diabetes 2с | 1 test | 77 630 |
| 498 | Molecular genetic diagnostic of mutation V617F in gene JAK2 during myeloproliferative disorder | 1 test | 35 100 |
| 499 | Molecular genetic assessment human microorganism ratio (microbiome ) | 1 test | 217 100 |
| 500 | Molecular genetic prenatal diagnosis of amniotic fluid cells on aneuploidy chromosomes 13, 18, 21, X, Y | 1 test | 72 800 |
| 501 | Molecular genetic analysis (genotyping) in gene mutation, associated with alteration of pharmacologic response | 1 test | 77 630 |
| 502 | Molecular genetic analysis of mutation in 12 genes associated with epidermolysis bullosa | 1 test | 227 500 |
| 503 | Molecular genetic analysis for sensebilety to imatinib for patients with Ph-chromosome during CML and ALLPh+ | 1 test | 37 700 |
| 504 | Pre-implantation molecular genetic screening of embryo on chromosomal pathologies by 24 chromosomes | 1 test | 143 000 |
| 505 | Molecular genetic diagnostic polymorphism susceptibility gene PNPLA3 and TM6SF2 during nonalcoholic steatohepatitis | 1 test | 18 460 |
| 506 | Establishment of gene mutations BRCA Oncomine Research Assay | 1 test | 414 700 |
| 507 | Establishment mutations, chimerical transcripts and copy types in 161 genes, associated with carcinoma development, panel ONCOMINE Comprehensive ASSAY | 1 test | 572 000 |
| 508 | Genealogic origin by Y-chromosome | 1 test | 102 050 |
| 509 | Gene mutation FLT3 (ITD, TKD - D835F) by malecular-genetic method | 1 test | 41 600 |
| 510 | Gene mutation JAK2 in 12 exon MLPA method (fragment analysis) | 1 test | 58 500 |
| 511 | Gene mutation PIK3CA by malecular-genetic method | 1 test | 58 500 |
| 512 | Gene mutation CFTR at mucoviscidosis | 1 test | 92 950 |
| 513 | Individual susceptibility to warfarin | 1 test | 48 750 |
| 514 | Micro-deletion (fragment analysis) MLPA method at motormental retardation | 1 test | 91 650 |
| 515 | Genotyping at amyotrophic lateral sclerosis | 1 test | 55 900 |
| 516 | Gene mutation KRAS | 1 test | 131 300 |
| 517 | Molecular genetic study of microsatellite instability (MSI) | 1 test | 148 200 |
| 518 | Determination of fetal Rh factor in maternal blood | 1 test | 60 450 |
| 519 | Gene mutation DNA | 1 test | 780 000 |
| 520 | Gene mutation NF1 gene in neurofibromatosis by MLPA | 1 test | 280 800 |
| 521 | Gene chimeric of KIAA-BRAF , BRAF V600E by MLPA method | 1 test | 117 000 |
| 522 | Gene amplification of ERBB2 (HER2) | 1 test | 104 000 |
| Glioma diagnostic | |||
| 523 | Aberrant methylation (MGMT) | 1 test | 59 150 |
| 524 | Gene mutation IDH1-IDH2 | 1 test | 59 150 |
| 525 | Mutation WNT, SHH- activation | 1 test | 81 250 |
| 526 | Gene mutation CDKN2A/2B | 1 test | 59 150 |
| 527 | Gene mutation EGFR | 1 test | 59 150 |
| 528 | Gene mutationATRX | 1 test | 59 150 |
| 529 | Gene mutation TP53 | 1 test | 59 150 |
| 530 | Co- expression 1p-19q | 1 test | 59 150 |
| 531 | Mutation H3K27 | 1 test | 136 500 |
| 532 | Gene mutation MYCN | 1 test | 59 150 |
| 533 | Mutation RELA fusion | 1 test | 118 950 |
| 534 | Gene C19MC, miRNA profiling | 1 test | 46 150 |
| 535 | Gene mutation VEGF | 1 test | 54 600 |
| 536 | Panel "Glioma" (mutation status of tumour cells during glioma) | 1 test | 559 000 |
Homepage
›
CLINICAL DIAGNOSTIC LABORATORY
